文献速递功能神经外科

自体肌肉微血管减压术治疗典型三叉神经痛的长期疗效:来自发展中国家的1025例患者分析

Long-term outcome of microvascular decompression for typical trigeminal neuralgia with autologous muscle: an analysis of 1025 patients from a developing country.
PubMed 文献 · J Neurosurg · 2024-04-12

该回顾性研究纳入2000至2019年间接受首次微血管减压术(MVD)并使用自体肌肉的典型三叉神经痛患者1025例,中位随访8年。术后86.7%患者疼痛完全缓解,10.3%部分缓解;1年、5年、10年、15年、20年无复发比例分别为97%、90%、85%、82%、81%。静脉压迫和无术后即刻疼痛缓解是复发的独立危险因素。

要点

  • 自体肌肉MVD术后86.7%完全缓解,10.3%部分缓解,2.9%无缓解。
  • 静脉压迫者MVD失败率5%(16/322),高于动脉压迫者的2%(14/703)(p=0.015)。
  • 静脉压迫(HR 1.62)和无即刻疼痛缓解(HR 2.65)与复发相关。

核心结论

  • 使用自体肌肉的MVD可为存在血管压迫的三叉神经痛患者提供持久疼痛缓解,并发症率低,是合成材料的可行替代方案。

研究设计与样本

  • 回顾性研究,纳入2000至2019年间在一家三级超区域神经外科中心接受首次MVD且未接受过手术干预的典型三叉神经痛患者1025例。
  • 采用Barron神经病学研究所(BNI)疼痛评分评估疼痛结局,使用卡方检验、Kaplan-Meier曲线和Cox回归分析。

主要发现

  • 术后即刻889例(86.7%)疼痛完全缓解,106例(10.3%)部分缓解,30例(2.9%)无缓解。
  • 中位随访8年(IQR 5-13年,范围3-20年)期间,141例(13.8%)复发,复发中位时间3年(IQR 2-6年)。
  • 无复发比例:1年97%、5年90%、10年85%、15年82%、20年81%。
  • 完全缓解者复发114/907(12.6%),部分缓解者复发19/106(17.9%),两组复发概率无显著差异(p=0.124,log-rank检验)。
  • 静脉压迫者MVD失败16/322(5%),动脉压迫者失败14/703(2%),差异显著(p=0.015,卡方检验)。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: The objective was to evaluate the long-term outcome of microvascular decompression (MVD) utilizing autologous muscle for trigeminal neuralgia (TGN). METHODS: A retrospective review was performed of all first-time MVD patients for typical classic TGN without prior surgical intervention who were treated between 2000 and 2019 at a tertiary supraregional neurosurgery practice. Demographic characteristics, surgical findings, operative results, complications, and recurrence rates at 1 year, 5 years, and last follow-up were collected. Pain outcome was assessed using the Barrow Neurological Institute (BNI) pain score. The chi-square test with continuity correction was used to compare categorical variables, and Kaplan-Meier curves and Cox regression were used to identify factors associated with recurrence. RESULTS: In total, 1025 patients were studied with a median (interquartile range [IQR]) (range) follow-up of 8 (5-13) (3-20) years. In the immediate postoperative period, 889 patients (86.7%) had complete pain relief and 106 (10.3%) had partial pain relief; neither group required medication, and 30 patients (2.9%) had no relief. One hundred forty-one recurrences (13.8%) occurred over a median (IQR) of 3 (2-6) years after surgery. The proportion of patients without recurrence was 97% at 1 year, 90% at 5 years, 85% at 10 years, 82% at 15 years, and 81% at 20 years. There was no significant difference in the probability of recurrence between patients with complete (114/907 [12.6%] recurrences) or partial (19/106 [17.9%] recurrences) postoperative pain relief (p = 0.124, log-rank test). Patients with venous compression (n = 322) had a significantly higher rate of MVD failure (n = 16 [5%]) compared to those with arterial compression (14/703 [2%]) (p = 0.015, chi-square test). In the Cox proportional hazards model, venous compression and lack of immediate postoperative pain relief had hazard ratios of 1.62 (95% CI 1.16-2.27) and 2.65 (95% CI 1.45-4.82) for recurrence, respectively. One hundred twenty-four (12.1%) complications were documented, including facial numbness (44 [4.3%]), facial nerve palsy (37 [3.6%]), CSF leak (13 [1.3%]), and diplopia (5 [0.5%]), which resolved in all patients. CONCLUSIONS: MVD with autologous muscle provides long-lasting pain relief in TGN patients with vascular compression with minimum morbidity and is a viable alternative to synthetic materials.

来源:J Neurosurg,查看原文。版权归原作者所有。

引用

  1. Ashraf M, Sajjad F, Hussain SS, et al. Long-term outcome of microvascular decompression for typical trigeminal neuralgia with autologous muscle: an analysis of 1025 patients from a developing country. J Neurosurg. 2024. PMID: 38608302. doi:10.3171/2023.9.JNS231473

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。